Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor...
Leadership
John P. Butler MBA
CEO, President & Director
Erik John Ostrowski M.B.A.
Chief Business Officer, Senior VP, CFO & Treasurer
Steven Keith Burke M.D.
Senior VP and Chief Research & Development Officer
Nicholas Grund
Senior VP & Chief Commercial Officer
Richard C. Malabre
Senior VP & Chief Accounting Officer
Justin McCue Ph.D.
Senior VP & Chief Technology Officer
Mercedes Carrasco
Senior Director of Investor & Corporate Communications
